Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
AFFF Lawsuit Exposure to firefighting foam chemicals may result in an increased risk of cancer for firefighters, military and airport personnel.
Paraquat Parkinson’s Disease Lawsuits Exposure to the toxic herbicide Paraquat has been linked to a risk of Parkinson's disease.
Hospira Carpuject Recall Issued Due to Potential Leaks of Some Drug Products Failure of the Carpuject injection seals may lead to the need for further medical treatment, the FDA warns. May 24, 2024 Grace Muller Add Your Comments The Pfizer subsidiary Hospira Inc. is recalling some of their injectable medications, following at least one complaint of leaks due to defective seals. A Carpuject recall was announced by the U.S Food and Drug administration (FDA) on May 22, after discovering that prefilled syringes of the Buprenorphine Hydrochloride Injection and Labetalol Hydrochloride Injection may experience leaks Carpujects are a ready-to-use prefilled syringe that allows for needle free access, it is made up of a calibrated glass drug vial and a plastic syringe. These devices help reduce medication errors, needle stick injuries, contamination, and decrease preparation time. Buprenorphine HCl Injection is used to manage pain that needs an opioid painkiller when other treatments aren’t enough. It is a clear, sterile injection introduced either into a vein or a muscle. Labetalol HCl Injection is used to control high blood pressure in severe cases. Do You Know about… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… hair dye cancer lawsuits For Salon Professionals Hair dye lawsuits are being pursued for salon professionals who were routinely exposed to hair dye chemicals and diagnosed with bladder cancer or breast cancer. See if you qualify for a hair dye cancer lawsuit settlement. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The FDA warns that the recalled products have an increased risk of the medication not working properly and an increased risk of systematic infection if the seals fail, which could lead to the need of further medical treatment. The Carpujects were distributed nation-wide to wholesalers and hospitals in the U.S from September 2023 until April 2024. The affected Buprenorphine Hydrochloride Injections come in cartons with NDC 0409-2012-32 and cartridges with NDC 0409-2012-03. Lot number HJ3965 expires in September 2024 and contains 0.3 mg base/mL concentration, with 10 cartridge units per carton. Lot number HJ8546 expires in October 2024 and also contains 0.3 mg base/mL concentration, with 10 cartridge units per carton. Labetalol Hydrochloride Injection comes in bundles with NDC 0409-2339-34 and cartons/cartridges with NDC 0409-2339-24. Lot number HJ7566 expires in May 2025 and contains 20 mg/4 mL (5 mg/mL) concentration, with 10 carton/cartridge units per bundle. Lot number HN8747 expires in September 2025 and also contains 20 mg/4 mL (5 mg/mL) concentration, with 10 carton/cartridge units per bundle. Lot number HN8749 also expires in September 2025 and contains 20 mg/4 mL (5 mg/mL) concentration, with 10 carton/cartridge units per bundle. Wholesalers and hospitals with affected products should immediately stop using and distributing them, and should place the product in quarantine. They should also inform customers, and any other locations that might have received them, about the recall. Healthcare professionals with questions about this recall can contact Pfizer for assistance. For medical questions regarding the product, they can reach Pfizer Medical Information at 800-438-1985, option 3, Monday through Friday from 9am to 5pm ET, or visit www.pfizermedinfo.com. To report adverse events and product complaints, contact Pfizer Drug Safety at 800-438-1985, option 1, available 24 hours a day, 7 days a week. Tags: Carpuject, Hospira, Pfizer, Syringe Recall More Lawsuit Stories Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion March 31, 2025 Tepezza Lawyers Meet With MDL Judge To Review Status of Hearing Loss Lawsuits Today March 31, 2025 Hospital Sepsis Risks Could Be Lessened With AI Model: Study March 31, 2025 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermCommentsThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: today) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025) Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 3 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer. Ozempic Delayed Gastric Emptying Led to Stomach Paralysis: Lawsuit (Posted: 4 days ago) A Mississippi woman’s Ozempic lawsuit indicates that she suffered stomach paralysis due to the drug’s delayed gastric emptying side effects, which left her with permanent injuries. MORE ABOUT: OZEMPIC LAWSUITCourt Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (03/21/2025)GLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)
Cartiva SCI Lawsuit Alleges Toe Implant Worsened Pain, Decreased Range of Motion (Posted: today) An Indiana woman has filed a Cartiva SCI implant lawsuit, indicating that the toe implant failed due to a defective design, resulting in the need for revision surgery and recommendations to permanently fuse her big toe. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Implant Injury Lawsuit Set for Trial in February 2026 (03/07/2025)Lawsuit Indicates Cartiva Implant Fails in 2 Out of 3 Patients, But Continued To Be Sold in U.S. (02/13/2025)Cartiva Toe Implant Lawsuit Filed Over Worsened Pain, Reduced Range of Motion and Need for Surgical Removal (02/07/2025)
Salon Professionals Claim Occupational Exposure to Hair Dye Products Caused Bladder Cancer: Lawsuits (Posted: 3 days ago) Two California hair stylists filed separate lawsuits, indicating that repeated occupational exposure to toxic chemicals in hair coloring dyes caused them to develop bladder cancer.
Ozempic Delayed Gastric Emptying Led to Stomach Paralysis: Lawsuit (Posted: 4 days ago) A Mississippi woman’s Ozempic lawsuit indicates that she suffered stomach paralysis due to the drug’s delayed gastric emptying side effects, which left her with permanent injuries. MORE ABOUT: OZEMPIC LAWSUITCourt Urged To Reject Motion To Dismiss Lawsuits Over Ozempic, Mounjaro Gastrointestinal Risks (03/21/2025)GLP-1 Manufacturers Argue Gastroparesis Lawsuits Should Require Contemporaneous Diagnostic Testing (03/17/2025)Study Suggests There May Not Be a Link Between Ozempic, Mounjaro and Post-Surgery Aspiration Pneumonia (03/12/2025)